Director Health Information Sciences, Quantitative Sciences, Janssen Pharm R&D
A former UK NHS healthcare & voluntary sector professional working in the pharmaceutical and diagnostics industry with a 360° experience in the blood borne virus market based on a professional heritage in the viral hepatitis, liver disease & HIV fields spanning thirty years, inclusive of ten years in the voluntary sector and being a Dept. of Health advisor. Formerly working for Roche, Gilead, Novartis, and now Janssen, he has focused latterly on strategic marketing for new diagnostic solutions for personalized medicine via bio-informatic tools, health information technologies and biomarkers in infectious or chronic diseases, with a particular emphasis on real world data. He now works on the IMI European Medical Information Framework (EMIF) and integration of real world evidence into Quantitative Sciences programs.